Home1S1 • FRA
add
Viridian Therapeutics Inc
Previous close
€24.36
Day range
€24.48 - €24.48
Year range
€9.60 - €28.58
Market cap
2.80B USD
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 132.00K | 83.33% |
Operating expense | 372.60M | 2,290.93% |
Net income | -120.36M | -50.96% |
Net profit margin | -91.18K | 17.66% |
Earnings per share | -1.08 | -33.33% |
EBITDA | -126.13M | -44.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 874.65M | 21.89% |
Total assets | 899.42M | 21.15% |
Total liabilities | 177.25M | 150.48% |
Total equity | 722.17M | — |
Shares outstanding | 102.21M | — |
Price to book | 4.20 | — |
Return on assets | -42.75% | — |
Return on capital | -48.58% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -120.36M | -50.96% |
Cash from operations | -23.75M | 67.61% |
Cash from investing | -339.42M | -439.49% |
Cash from financing | 405.91M | 1,042.63% |
Net change in cash | 42.74M | 142.43% |
Free cash flow | -31.73M | 32.20% |
About
Founded
2010
Headquarters
Website
Employees
252
